의약품 관련 법령
Disposition 513/2019: Marketing Authorization Applications Requirements for Synthetic and/or Semi-Synthetic Medicinal Products with APIs that do not Require Bioequivalence and/or Biodisponibility Demonstration
작성자 | 관리자 | ||
---|---|---|---|
작성일 | 2019-01-15 | 조회수 | 1,920 |
국가정보 | 남 아메리카>아르헨티나 | ||
출처 | BOLETINOFICIAL | ||
원문 | www.boletinoficial.gov.ar | ||
첨부파일 |
Disposition 513/2019: Marketing Authorization Applications Requirements for Synthetic and/or Semi-Synthetic Medicinal Products with APIs that do not Require Bioequivalence and/or Biodisponibility Demonstration
- 이전글 Official Notice: Authorization for the Import/Export of Biological Samples Linked to Clinical Trials
- 다음글 PEI: List of Compassionate Use Programms of the Paul-Ehrlich Institut